Garry Blessed

2.9k citations
15 papers · 2.0k indexed · 1 hit paper · h-index 11
Topics
Cholinesterase and Neurodegenerative Diseases (8 papers)Alzheimer's disease research and treatments (5 papers)Neurological Disorders and Treatments (3 papers)

In The Last Decade

Garry Blessed

15 papers receiving 1.9k citations

Hit Papers

Neurotransmitter enzyme abnormalities in senile dementia19772026199320091977100200300400500

Peers

Garry Blessed
Comparison fields: 5 of 95
  • Physiology 849
  • Cellular and Molecular Neuroscience 705
  • Pharmacology 678
  • Molecular Biology 626
  • Psychiatry and Mental health 409
Replace Margaret A. Piggott with:
Margaret A. Piggott United Kingdom
David M. Bowen United Kingdom
Robert Perry United Kingdom
PJ Whitehouse United States
Philip D. Kanof United States
Pierre Étienne Canada
R. G. Struble United States
Ewa Hellström‐Lindahl Sweden
Kenneth L. Davis United States
K. Reinikainen Finland
Garry Blessed relative to Margaret A. Piggott United Kingdom Margaret A. Piggott's profile →
Citations per field
00.5×1.5×
Margaret A. Piggott · 1×
Citations per year

Countries citing papers authored by Garry Blessed

Since Specialization
Citations

This map shows the geographic impact of Garry Blessed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Blessed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Blessed more than expected).

Fields of papers citing papers by Garry Blessed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Blessed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Blessed. The network helps show where Garry Blessed may publish in the future.

Co-authorship network of co-authors of Garry Blessed

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Blessed. A scholar is included among the top collaborators of Garry Blessed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Blessed. Garry Blessed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1
Blessed Roth Dementia Scale 1968
9
2 47
3 68
4 443
5 76
6 1
7 1
8 78
9 1
10 170
11 138
12 101
13 89
14 185
15
Neurotransmitter enzyme abnormalities in senile dementiabreakdown →
585

About Garry Blessed

Garry Blessed is a scholar working on Pharmacology, Neurology and Behavioral Neuroscience, having authored 15 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (8 papers), Alzheimer's disease research and treatments (5 papers) and Neurological Disorders and Treatments (3 papers). The work is most often cited by research in Pharmacology (678 citations), Cellular and Molecular Neuroscience (705 citations) and Biological Psychiatry (83 citations). Garry Blessed has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Elaine K. Perry, Robert H. Perry, B.E. Tomlinson, Peter H. Gibson, Andrew Fairbairn, Dorothy Irving, John Atack, James R. Bonham, A.J. Cross and Timothy J. Crow. Their work appears in journals such as Journal of Neurochemistry, The British Journal of Psychiatry and Journal of the Neurological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026